Similar articles

• Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

  Chun FK, Briganti A, Gallina A, Hutterer GC, Shariat SF, Antebie E, Walz J, Roehrborn CG, Salonia A, Rigatti P, Saad F, Huland H, Montorsi F, Graefen M, Karakiewicz PI. Chun FK, et al. Eur Urol. 2007 Oct;52(4):1067-74. doi: 10.1016/j.eururo.2007.03.018. Epub 2007 Mar 20. Eur Urol. 2007. PMID: 17383807
• Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

  Trpkov K. Trpkov K. Eur Urol. 2007 Sep;52(3):743-4. doi: 10.1016/j.eururo.2007.02.055. Eur Urol. 2007. PMID: 17350751 No abstract available.
• Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

  Greene DR. Greene DR. Eur Urol. 2007 Sep;52(3):744-5. doi: 10.1016/j.eururo.2007.02.056. Eur Urol. 2007. PMID: 17350749 No abstract available.
• 'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.

  Johnstone PA, Rossi PJ, Jani AB, Master V. Johnstone PA, et al. Prostate Cancer Prostatic Dis. 2007;10(3):237-41. doi: 10.1038/sj.pcan.4500963. Epub 2007 Mar 27. Prostate Cancer Prostatic Dis. 2007. PMID: 17387320 Review.
• [PSA kinetics after total prostatectomy].

  Riedinger JM, Eche N, Fulla Y, Thuillier F. Riedinger JM, et al. Ann Biol Clin (Paris). 2009 Jan-Feb;67(1):39-46. doi: 10.1684/abc.2009.0298. Ann Biol Clin (Paris). 2009. PMID: 19189884 Review. French.